TY - JOUR
T1 - Placement of balloon-expandable intraluminal stents in iliac arteries
T2 - First 171 procedures
AU - Palmaz, Julio C.
AU - Garcia, Oscar J.
AU - Schatz, Richard A.
AU - Rees, Chet R.
AU - Roeren, Thomas
AU - Richter, Goetz M.
AU - Noeldge, Gerd
AU - Gardiner, Geoffrey A.
AU - Becker, Gary J.
AU - Walker, Craig
AU - Stagg, Jody
AU - Katzen, Barry T.
AU - Dake, Michael D.
AU - Paolini, Rosa Maria
AU - McLean, Gordon K.
AU - Lammer, Johannes
AU - Schwarten, Donald E.
AU - Tio, Fermin O.
AU - Root, Harlan D.
AU - Rogers, Waid
PY - 1990/3
Y1 - 1990/3
N2 - Balloon-expandable intraluminal stents were used to treat iliac artery stenoses or occlusions that failed to respond to conventional balloon angioplasty. One hundred seventy-one procedures were performed in 154 patients, of whom 48 had a limb at risk for amputation. Thirty-six had severe and 70 had moderate intermittent claudication. At the latest follow-up examination (average, 6 months; range, 1-24 months), 137 patients demonstrated clinical benefit, 113 of whom had become asymptomatic. Eleven patients showed no initial benefit, and six improved initially but later developed new vascular symptoms. Complications occurred in 18 patients. In three patients, complications were directly related to the device. Two occlusions were successfully recanalized, and an intramural collection of contrast material secondary to balloon perforation evolved favorably. The remaining patients had groin hematoma (n = 6), distal embolization (n = 4), extravasation (n = 2), transient renal failure (n = 1), pseudoaneurysm at the puncture site (n = 1), or subintimal dissection (n = 1). All stents have remained patent to the latest follow-up examination without evidence of migration or aneurysm formation.
AB - Balloon-expandable intraluminal stents were used to treat iliac artery stenoses or occlusions that failed to respond to conventional balloon angioplasty. One hundred seventy-one procedures were performed in 154 patients, of whom 48 had a limb at risk for amputation. Thirty-six had severe and 70 had moderate intermittent claudication. At the latest follow-up examination (average, 6 months; range, 1-24 months), 137 patients demonstrated clinical benefit, 113 of whom had become asymptomatic. Eleven patients showed no initial benefit, and six improved initially but later developed new vascular symptoms. Complications occurred in 18 patients. In three patients, complications were directly related to the device. Two occlusions were successfully recanalized, and an intramural collection of contrast material secondary to balloon perforation evolved favorably. The remaining patients had groin hematoma (n = 6), distal embolization (n = 4), extravasation (n = 2), transient renal failure (n = 1), pseudoaneurysm at the puncture site (n = 1), or subintimal dissection (n = 1). All stents have remained patent to the latest follow-up examination without evidence of migration or aneurysm formation.
KW - Arteries, extremities, 98.721
KW - Arteries, grafts and prostheses, 98.456
KW - Arteries, iliac, 98.721
KW - Arteries, stenosis or obstruction, 98.721
KW - Arteries, transluminal angioplasty, 98.128
KW - Arteriosclerosis, 98.721
UR - http://www.scopus.com/inward/record.url?scp=0025304837&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025304837&partnerID=8YFLogxK
M3 - Article
C2 - 2137638
AN - SCOPUS:0025304837
SN - 0033-8419
VL - 174
SP - 969
EP - 975
JO - Radiology
JF - Radiology
IS - 3 PART 2
ER -